SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes routine cGMP inspection at formulations manufacturing facility of Dr. Reddy's

30 Oct 2023 Evaluate

United States Food & Drug Administration (USFDA) has completed a routine cGMP inspection at Dr. Reddy's Laboratories’ formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from October 19, 2023 to October 27, 2023. USFDA has issued a Form 483 with ten observations. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1336.95 35.65 (2.74%)
24-Jun-2026 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1876.45
Dr. Reddys Labs. 1336.95
Cipla 1446.15
Zydus Lifesciences 1101.00
Lupin 2380.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: